Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02861053
Other study ID # 2016/013/HP
Secondary ID
Status Recruiting
Phase N/A
First received August 5, 2016
Last updated August 29, 2017
Start date September 2016
Est. completion date April 2018

Study information

Verified date August 2017
Source University Hospital, Rouen
Contact David DEBEAUMONT, MD
Email david.debeaumont@chu-rouen.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The chronic fatigue is observed in approximately 40 % of the patients with a chronic quiet inflammatory bowel disease (IBD) and impacts the quality of life of the patients. The beneficial role of a regular physical activity on the quality of life of patients having an IBD was demonstrated in 5 studies including only 1 controlled one [Bilski, on 2013]. The mechanism by which the physical activity could improve the quality of life of the patients remains unknown (stress decreased, reduction of the inflammatory process) [Bilski, on 2014]. Several studies concerning other chronic pathologies such as fibromyalgia, have demonstrated the beneficial effect of a regular physical exercise to reduce the fatigue of patients. It was recently demonstrated that the chronic fatigue observed in patients with IBD came along with a physical reduction in the performances during the exercise test and a reduction in the physical activity of the patients [Vogelaar, 2015].

Our hypothesis is that a regular moderate physical activity could improve physical performance during an effort et could reduce the chronic fatigue and improve their quality of life.


Recruitment information / eligibility

Status Recruiting
Enrollment 10
Est. completion date April 2018
Est. primary completion date April 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Patients = 18 years old

- Patients suffering from IBD

- Patients with a FACIT score < 30

- Patients with BD in remission with a C-reactiv protein dose < 5

- Patients with Hemoglobin dosage > 10g/dl

- Patients with 18<BMI<30 kg/m2

- Informed consent given by the patients

- Patients affiliated to the social security

- Patients living not far from the centre where the rehabilitation program will be performed

- Women with no risk of pregnancy (menopausal women or with contraceptive drugs).

Exclusion Criteria:

- Patients = 45 years old

- Inability to walk or to ride a bike

- Contraindication to practice physical exercise

- Contraindication to exercise test

- Participation to another research study within the week preceding the beginning of the protocol

- Patients unstable smokers

- Patients unable to keep their medical treatment stable along the study

- Patients with a regular intensive physical practice

- Patients with depression (HAD>11/21)

- Patients with bad sleep quality (PSQI score >5)

- Pregnant or breast-feeding patients

- Patients under legal protection

Study Design


Intervention

Other:
regular and moderate physical activity
regular and moderate physical activity will be done 3 times per week more than usual
No regular and moderate physical activity more than usual
regular and moderate physical activity will be done as usual

Locations

Country Name City State
France Rouen University Hospital Rouen

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Rouen

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difference from baseline in the evaluation of fatigue Evaluation of fatigue using FACIT questionnaire 3 Month
Secondary Difference from baseline in the Evaluation of the Quality of life Evaluation of the Quality of life using Quality of life scores (IBDQ) 3 Month
Secondary Difference from baseline in the Evaluation of the Quality of life Evaluation of the Quality of life using Quality of life scores (SF36) 3 Month
See also
  Status Clinical Trial Phase
Withdrawn NCT03278912 - Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations
Terminated NCT00061282 - Clotrimazole Enemas for Pouchitis in Children and Adults Phase 1/Phase 2
Recruiting NCT05579392 - A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis N/A
Completed NCT03264690 - Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients
Recruiting NCT02275676 - Resting Energy Expenditure and Nutritional Status in IBD N/A
Completed NCT02197780 - Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD N/A
Completed NCT02503696 - Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD) N/A
Completed NCT02161640 - Vascular Dysfunction in Paediatric IBD N/A
Completed NCT01933867 - Water-aided Colonoscopy in Inflammatory Bowel Disease Patients N/A
Completed NCT01852760 - Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound N/A
Completed NCT01860651 - Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease N/A
Completed NCT01692743 - Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD) Phase 3
Completed NCT01676324 - FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD) N/A
Completed NCT01666535 - Infliximab IBD Influenza Vaccine Study N/A
Completed NCT01688557 - Trial on Innovative Technologies in Colonoscopy N/A
Completed NCT01557387 - Real-time Diagnosis of Pseudopolyps During Colonoscopy
Completed NCT01981616 - Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab Phase 1
Completed NCT01221818 - A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects Phase 1
Completed NCT01476995 - Prognostic Indicators as Provided by the EPIC ClearView N/A
Completed NCT02322008 - Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice N/A